CVS Health (CVS)
(Delayed Data from NYSE)
$58.75 USD
+1.01 (1.75%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $58.89 +0.14 (0.24%) 7:58 PM ET
5-Strong Sell of 5 5
A Value D Growth F Momentum C VGM
Income Statements
Fiscal Year end for CVS Health Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 357,776 | 322,467 | 292,111 | 268,706 | 256,776 |
Cost Of Goods | 217,098 | 196,892 | 175,803 | 163,981 | 158,719 |
Gross Profit | 140,678 | 125,575 | 116,308 | 104,725 | 98,057 |
Selling & Adminstrative & Depr. & Amort Expenses | 126,935 | 117,829 | 103,115 | 90,814 | 86,070 |
Income After Depreciation & Amortization | 13,743 | 7,746 | 13,193 | 13,911 | 11,987 |
Non-Operating Income | 88 | 169 | -270 | -1,234 | 45 |
Interest Expense | 2,658 | 2,287 | 2,503 | 2,907 | 3,035 |
Pretax Income | 11,173 | 5,628 | 10,420 | 9,770 | 8,997 |
Income Taxes | 2,805 | 1,463 | 2,522 | 2,569 | 2,366 |
Minority Interest | 24 | 16 | -12 | 13 | -3 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 8,368 | 4,165 | 7,898 | 7,201 | 6,631 |
Extras & Discontinued Operations | 0 | 0 | 0 | -9 | 0 |
Net Income (GAAP) | 8,344 | 4,149 | 7,910 | 7,179 | 6,634 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 18,109 | 11,993 | 18,136 | 18,352 | 16,358 |
Depreciation & Amortization (Cash Flow) | 4,366 | 4,247 | 4,943 | 4,441 | 4,371 |
Income After Depreciation & Amortization | 13,743 | 7,746 | 13,193 | 13,911 | 11,987 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 1,290.00 | 1,323.00 | 1,329.00 | 1,314.00 | 1,305.00 |
Diluted EPS Before Non-Recurring Items | 8.74 | 8.69 | 8.40 | 7.50 | 7.08 |
Diluted Net EPS (GAAP) | 6.47 | 3.14 | 5.95 | 5.46 | 5.08 |
Fiscal Year end for CVS Health Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 91,234.00 | 88,437.00 | 93,813.00 | 89,764.00 | 88,921.00 |
Cost Of Goods | 49,998.00 | 48,073.00 | 57,419.00 | 54,688.00 | 53,536.00 |
Gross Profit | 41,236.00 | 40,364.00 | 36,394.00 | 35,076.00 | 35,385.00 |
SG&A, R&D, and Dept/Amort Expenses | 38,191.00 | 38,093.00 | 33,021.00 | 31,386.00 | 32,151.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 3,045.00 | 2,271.00 | 3,373.00 | 3,690.00 | 3,234.00 |
Non-Operating Income | 24.00 | 25.00 | 22.00 | 22.00 | 22.00 |
Interest Expense | 732.00 | 716.00 | 690.00 | 693.00 | 686.00 |
Pretax Income | 2,337.00 | 1,580.00 | 2,705.00 | 3,019.00 | 2,570.00 |
Income Taxes | 569.00 | 456.00 | 658.00 | 754.00 | 656.00 |
Minority Interest | -2.00 | 11.00 | 1.00 | 4.00 | 13.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 1,768.00 | 1,124.00 | 2,047.00 | 2,265.00 | 1,914.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 1,770.00 | 1,113.00 | 2,046.00 | 2,261.00 | 1,901.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 1,259.00 | 1,267.00 | 1,293.00 | 1,290.00 | 1,287.00 |
Diluted EPS Before Non-Recurring Items | 1.83 | 1.31 | 2.12 | 2.21 | 2.21 |
Diluted Net EPS (GAAP) | 1.41 | 0.88 | 1.59 | 1.75 | 1.48 |